
About Samrat Remedies Limited
Data last updated:
Samrat Remedies Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 August 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2003PLC392453.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.07 Cr. It is led by directors including Hitesh Champak Parekh (Managing Director) and Champaklal Kantilal Parekh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 208 2nd Floor De Elmas Pahadi Village Sonawala Cross Lane No. 2 Goregaon East, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2023, the company reported a revenue of ₹12.76 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.77 Cr (net margin 68.8%) and EBITDA of ₹11.05 Cr (EBITDA margin 86.6%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 27% over five years.
The company has about 7 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Samrat Remedies. As per MCA filings, the company has satisfied charges of ₹8.91 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹2.89 Cr; the latest was in June 2023. Its 4 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Chemtech Finechem Private Limited with revenue of ₹71.87 Lakh. The company has 2 MSME Form 1 returns on record for the period ending Sep 2020, listing 25 overdue payments to 6 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website samratremedies.com.
Company details
CIN history
Samrat Remedies has one previous CIN (Corporate Identification Number): U24231GJ2003PLC042774. The current CIN is U24231MH2003PLC392453, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MH2003PLC392453 | Current |
| U24231GJ2003PLC042774 | Previous |
Contact details
Samrat Remedies Limited's registered office is in Mumbai, Maharashtra. Its website is samratremedies.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address208 2nd Floor De Elmas Pahadi Village Sonawala Cross Lane No. 2 Goregaon East, Mumbai, Maharashtra, India – 400063
- IndustryPharma, API Manufacturers
To see the full contact details of Samrat Remedies Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Samrat Remedies operates one associated brand: Samrat Remedies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports fine chemicals and pharmaceutical intermediates globally. | samratremedies.com |
Financials of Samrat Remedies Limited
FY 2024 filings availableSamrat Remedies Limited reported revenue of ₹12.76 Cr (up 1862% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 27% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹12.76 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.77 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 86.6% | ||||
| Net Profit Margin | 68.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Samrat Remedies Limited, buy the company report.
Board of directors of Samrat Remedies Limited
Samrat Remedies has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Champaklal Kantilal Parekh | Whole-Time Director | 25 Aug 2003 | 23 Years 2 Months | Current |
| Hitesh Champak Parekh Also directs: Samrat Remedies India Private Limited | Managing Director | 25 Aug 2003 | 23 Years 2 Months | Current |
| Saroj Champaklal Parekh | Whole-Time Director | 16 Sep 2005 | 21 Years 2 Months | Current |
| Sangeeta Hitesh Parekh Also directs: Samrat Remedies India Private Limited | Whole-Time Director | 16 Sep 2005 | 21 Years 2 Months | Current |
Peer comparison
Samrat Remedies Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Samrat Remedies Limitedthis company | ₹12.76 Cr (FY 2023) | ₹8.77 Cr | 68.8% | 1862.0% | 7 | Mumbai, Maharashtra, India |
| Chemtech Finechem Private Limited | ₹71.87 Lakh (FY 2025) | -73.0% | Vadodara, Gujarat, India | |||
| Hatri Pharma Private Limited | ₹71.68 Lakh (FY 2025) | -93.0% | Hyderabad, Telangana, India | |||
| Syngenesis Chemscience Private Limited | ₹66.12 Lakh (FY 2025) | -20.0% | Nashik, Maharashtra, India | |||
| Ascentus Organics Private Limited | ₹63.59 Lakh (FY 2025) | 32.0% | Sinnar, Maharashtra, India |
To see the full peer comparison of Samrat Remedies Limited, buy the company report.
Auditor
Samrat Remedies Limited is audited by NALIN S PAREKH & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NALIN S PAREKH & CO | FY 2023 | 106842W |
Shareholding
The shareholding of Samrat Remedies Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Samrat Remedies Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Aug 2008 | 10133784 | Others | ₹3.6 Cr | Satisfied | |
| 30 Jan 2008 | 10102043 | The Saraswat Co-Operative Bank Limited | ₹55.5 Lakh | Satisfied | |
| 15 Apr 2006 | 10004406 | The Saraswat Co-Operative Bank Limited | ₹1.5 Cr | Satisfied | |
| 15 Apr 2006 | 80017200 | The Saraswat Co-Operative Bank Limited | ₹3.25 Cr | Satisfied |
To see the full charge records of Samrat Remedies Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Samrat Remedies Limited has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹2.89 Cr; the latest was in June 2023.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Riza Company Limited |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Central Chemical INC |
| Sep 2007 | Secondary share transfer | Undisclosed | Buyer: Hitesh Champak Parekh HUF, 2 individuals Seller: Kush Hindustan Entertainment Limited , Hema Trading Co. Private Limited, Real Gold Trading Company Private Limited |
| Sep 2006 | Funding round | ₹50 Lakh | Investors: Javda India Impex Limited , Hema Trading Co. Private Limited, Kush Hindustan Entertainment Limited |
| Dec 2005 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Samrat Pharmachem Limited & Champak C Parekh, Samrat Pharmachem Limited & Saroj C Parekh, Samrat Pharmachem Limited & Sangeeta Hitesh Parekh |
To see the full deal history of Samrat Remedies Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Samrat Remedies Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by The Principal Commissioner of Income Tax , Valsad | Disposed |
To see the full case history of Samrat Remedies Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Samrat Remedies Limited was last rated by Icra on 18 Jun 2015.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 18 Jun 2015 |
To see the full credit ratings and regulatory alerts of Samrat Remedies Limited, buy the company report.
MSME payment delays
Samrat Remedies Limited has 2 MSME Form 1 returns on record for the period ending Sep 2020, listing 25 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Jigs Chemical Limited | |||
| Eskay Iodine Private Limited | |||
| Rishabh Intermediates | |||
| Interplastica Bharat Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Samrat Remedies Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Samrat Remedies has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Samrat Remedies India Private Limited | U24100MH1985PTC035969 |
To see the full group structure of Samrat Remedies Limited, buy the company report.
Employees & EPFO
Samrat Remedies Limited has a workforce of 7 employees on its EPFO records as of Mar 2020.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2019-20 | 7 |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Samrat Remedies Limited, buy the company report.
GST
No GST registration is on our record for Samrat Remedies Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Samrat Remedies Limited has 7 board changes on record since 2003: 4 appointments and 3 cessations. The latest: Champaklal Kantilal Parekh ceased to be Director on 01 Jan 2012.
10 earlier events are in the company report.
Frequently asked questions
Samrat Remedies is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 August 2003 (23+ years old) and is registered under CIN U24231MH2003PLC392453.
Samrat Remedies has 4 current directors:
- Hitesh Champak Parekh - Managing Director
- Champaklal Kantilal Parekh - Whole-Time Director
- Saroj Champaklal Parekh - Whole-Time Director
- Sangeeta Hitesh Parekh - Whole-Time Director
The latest financial statements of Samrat Remedies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Samrat Remedies is U24231MH2003PLC392453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samrat Remedies has 1 court case on record: 1 filed against it.
Samrat Remedies was incorporated on 21 August 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Samrat Remedies has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹2.89 Cr; the latest was in June 2023.
The peers of Samrat Remedies by revenue are Chemtech Finechem Private Limited, Hatri Pharma Private Limited, Syngenesis Chemscience Private Limited, Ascentus Organics Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Champaklal Kantilal Parekh ceased to be Director on 01 Jan 2012. Sangeeta Hitesh Parekh ceased to be Director on 01 Jan 2012. Saroj Champaklal Parekh ceased to be Director on 01 Jan 2012. Samrat Remedies has 7 board changes on record in total.
Samrat Remedies has 2 MSME Form 1 returns on record for the period ending Sep 2020, listing 25 overdue payments to 6 micro and small suppliers. The latest return was filed on 11 Dec 2020.
Samrat Remedies can be reached through the website samratremedies.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Samrat Remedies is at 208 2nd Floor De Elmas Pahadi Village Sonawala Cross Lane No. 2 Goregaon East, Mumbai, Maharashtra, India – 400063.

